1、European IVD MarketStatistics Report11,10011,20011,30011,26511,40011,00010,90010,80010,70010,60010,50020092010201120122013201420152016201720182019EUROPEAN IVD MARKET REVENUES(MILLION)OverviewMedTech Europe is pleased to publish the market estimates of the In vitro diagnostic(IVD)industry in Europe.T

2、he MedTech Europe figures include market size and dynamics information,based on 2019 and 2018 data.Macroeconomic and healthcare data are also included for all 28 EU-member states plus the European Free Trade Association members(EFTA)Switzerland,Norway and Iceland.In vitro diagnostics(IVDs)are an ess

3、ential part of todays healthcare.IVDs are used to diagnose,monitor,screen and assess predispositions to diseases,thereby contributing to the available medical information regarding a patient.By allowing earlier and more targeted treatments,IVDs help to reduce hospital stays and convalescences,result

4、ing in healthier populations,reduced costs and economic growth in the long run.Three out of the five largest European IVD markets France,Spain and UK are showing slight to moderate growth in 2019 and overall revenues across EU-28 plus EFTA reached 11,265 million,an increase of+1.5%.If changes in the

5、 value of non-Euro currencies,are considered the overall change in the Euro value of the European IVD market from 2018 to 2019 is+1.3%.The IVD revenues in Germany stagnated(-0.4%),further market decrease was seen in the reagents market(-1.2%).In Italy,the IVD market decreased(-2%),with decreased rev

6、enues in both clinical chemistry,(-7.6%)and haematology,(-2.7%).From the largest five markets,the UK is experienced the highest increase of+3.1%,largely due to increase in instruments and consumables,infectious disease testing,and nucleic acid testing systems.In Spain,the IVD market increased by+2.8